Quantitative analysis of tumor growth rate and changes in tumor marker level: Specific growth rate versus doubling time

Acta Oncologica

Volumn 48, Issue 4, 2009, Pages 591-597

  Mehrara, Esmaeil ^a   Forssell Aronsson, Eva ^a   Ahlman, Hkan ^a   Bernhardt, Peter ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; GROWTH RATE; INTERMETHOD COMPARISON; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME; BLOOD; CELL PROLIFERATION; COMPARATIVE STUDY; HUMAN; MATHEMATICAL COMPUTING; METABOLISM; NEOPLASM; PATHOLOGY; TIME;

TUMOR MARKER;

CELL PROLIFERATION; COMPUTER SIMULATION; HUMANS; MATHEMATICAL COMPUTING; NEOPLASMS; TIME FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 65549127794     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802616736     Document Type: Article

References (18)

1. Holland JF. Cancer medicine. Philadelphia: Lea & Febiger; 1993.
2. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007;/242:/ 555-62.
3. Collins VP, Loeffler RK, Tivey H. Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 1956;/76:/988-1000.
4. Mehrara E, Forssell-Aronsson E, Ahlman H, Bernhardt P. Specific growth rate versus doubling time for quantitative characterization of tumor growth rate. Cancer Res 2007;/67:/ 3970-5.
5. Guess B, Jennrich R, Johnson H, Redheffer R, Scholz M. Using splines to detect changes in PSA doubling times. Prostate 2003;/54:/88-94.
6. Nishida K, Kaneko T, Yoneda M, Nakagawa S, Ishikawa T, Yamane E, et al. Doubling time of serum CA 19-29 in the clinical course of patients with pancreatic cancer and its significant association with prognosis. J Surg Oncol 1999;/71:/ 140-6.
7. Arai T, Kuroishi T, Saito Y, Kurita Y, Naruke T, Kaneko M. Tumor doubling time and prognosis in lung cancer patients: Evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening Research Group. Jpn J Clin Oncol 1994;/24:/199-204.
8. Kuroishi T, Tominaga S, Morimoto T, Tashiro H, Itoh S, Watanabe H, et al. Tumor growth rate and prognosis of breast cancer mainly detected by mass screening. Jpn J Cancer Res 1990;/81:/454-62.
9. Balmukhanov SB, Turdugulov I, Karibjanova Z, Revesz L. The growth rate of bone sarcomas and survival after radiotherapy with tourniquet-induced hypoxia: A clinical study. Cancer 1982;/49:/1597-604.
10. Shiomi S, Nishiguchi S, Ishizu H, Iwata Y, Sasaki N, Tamori A, et al. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol 2001;/96:/1877-80.
11. Duhaylongsod FG, Lowe VJ, Patz EF, Jr., Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995;/60:/1348-52.
12. Tsunoda A, Shibusawa M, Tsunoda Y, Yasuda N, Koike T. Reduced growth rate of dimethylhydrazine-induced colon tumors in rats. Cancer Res 1992;/52:/696-700.
13. Spratt JS, Jr. The lognormal frequency distribution and human cancer. J Surg Res 1969;/9:/151-7.
14. Usuda K, Saito Y, Sagawa M, Sato M, Kanma K, Takahashi S, et al. Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer 1994;/74:/2239- 44. (Pubitemid 24322277)
15. Shackney SE, McCormack GW, Cuchural GJ, Jr. Growth rate patterns of solid tumors and their relation to responsiveness to therapy: An analytical review. Ann Intern Med 1978;/89:/107-21.
16. Spratt JS, Jr., Spratt TL. Rates of growth of pulmonary metastases and host survival. Ann Surg 1964;/159:/161-71.
17. Lee JY, Kim CK, Choi D, Park BK. Volume doubling time and growth rate of renal cell carcinoma determined by helical CT: A single-institution experience. Eur Radiol 2008;/ 18:/731-7.
18. Satkauskas S, Batiuskaite D, Salomskaite-Davalgiene S, Venslauskas MS. Effectiveness of tumor electrochemotherapy as a function of electric pulse strength and duration. Bioelectrochemistry (Amsterdam, Netherlands) 2005;/65:/ 105-11.